ORION BIOTECH OPPORTUNTES CO - *W EXP 04/15/202 (ORIAW)

CUSIP: G6780C117

Q3 2021 13F Holders as of 30 Sep 2021

Type / Class
Equity / *W EXP 04/15/202
Total 13F shares
1,328,093
Share change
+1,328,093
Total reported value
$1,430,000
Price per share
$0.88
Number of holders
16
Value change
+$1,430,000
Number of buys
16

Quarterly Holders Quick Answers

What is CUSIP G6780C117?
CUSIP G6780C117 identifies ORIAW - ORION BIOTECH OPPORTUNTES CO - *W EXP 04/15/202 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ORION BIOTECH OPPORTUNTES CO - *W EXP 04/15/202 (ORIAW) as of Q3 2021

As of 30 Sep 2021, ORION BIOTECH OPPORTUNTES CO - *W EXP 04/15/202 (ORIAW) was held by 16 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,328,093 shares. The largest 10 holders included 683 Capital Management, LLC, FIR TREE CAPITAL MANAGEMENT LP, Spring Creek Capital LLC, MMCAP International Inc. SPC, Arena Capital Advisors, LLC- CA, Fortress Investment Group LLC, Atalaya Capital Management LP, CNH PARTNERS LLC, DG Capital Management, LLC, and RIVERNORTH CAPITAL MANAGEMENT, LLC. This page lists 16 institutional shareholders reporting positions in this security for the Q3 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.